Abstract
Of 4257 patients with gestational trophoblastic disease (GTD) registered between 1986 and 1996 with the Trophoblastic Screening and Treatment Centre, Sheffield, 231 women required chemotherapy; 28 were treated 24 weeks or more after the initial evacuation of products of conception. In 18 patients late treatment was a result of a predetermined watch and wait policy on the part of the Centre; these patients formed the study group. Patients were identified from the Centre’s computer database. The time interval from first evacuation (diagnosis) to start of chemotherapy was calculated for each patient. Hospital records were reviewed when the interval of observation was 24 weeks or greater to determine patient characteristics, treatment and outcome. Eighteen women were treated ‘late’ (according to Centre policy), with a median age of 30 years (range 21–57 years). The interval from diagnosis to treatment ranged from 24 to, in one case, 56 weeks (median 33 weeks). Fourteen of 18 women had complete moles, 3/18 had partial moles and one had unclassified disease. All women had low-risk disease and were treated with single-agent methotrexate; 17 were cured with this regimen, one also required salvage chemotherapy. In conclusion, where a successful surveillance programme is in operation for GTD, a wait and watch policy can be adopted without compromising patients whose definitive treatment is commenced more than 6 months after the initial diagnosis. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bagshawe KD (1976) Risk and prognostic factors in trophoblastic neoplasia. Cancer 38: 1373–1385
Berkowitz RS and Goldstein DP (1997) Presentation and management of molar pregnancy. In: Gestational Trophoblastic Disease Hancock BW, Newland ES, Berkowitz RS (eds), pp. 127–142. Chapman & Hall: London
Gillespie AM, Lorigan PC, Radstone CR, Waterhouse JC, Coleman RE and Hancock BW (1997) Pulmonary function in patients with trophoblastic disease treated with low-dose methotrexate. Br J Cancer 76: 1382–1386
Goldstein DP and Berkowitz RS (1982) The diagnosis and management of molar pregnancy. In: Gestational Trophoblastic Neoplasms: Clinical Principles of Diagnosis and Management pp. 143–175. WB Saunders: Philadelphia
Hancock BW (1997) Differences in management and treatment: a critical appraisal. In: Gestational Trophoblastic Disease Hancock BW, Newlands ES and Berkowitz RS (eds), pp. 213–218. Chapman & Hall: London
Lurain JR, Brewer JI, Torok EE and Halpern B (1983) Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 145: 591–595
Rustin GJS, Pektasides D, Bagshawe KD, Newlands ES and Begent RHJ (1987) Fertility after chemotherapy for male and female germ cell tumours. Inst J Androl 10: 389–392
Rustin GJS, Newlands ES, Lutz JM, Holden L, Bagshawe KD, Hiscox JG, Foskett M, Fuller S and Short D (1996) Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumours increases the incidence of second tumours. J Clin Oncol 14: 2769–2773
Sharma S, Jagdev S, Coleman RE, Hancock BW and Lorigan PC (1999) Serosal complications of single agent low dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate induced peritonitis. Br J Cancer 81: 1037–1041
Sheridan E, Hancock BW, Smith SC, Dorreen MS, Neal FE, Pennington GW and Millar DR (1993) Gestational trophoblastic disease. Experience of the Sheffield (United Kingdom) supraregional screening and treatment service. Int J Oncol 3: 149–155
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gillespie, A., Kumar, S. & Hancock, B. Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy. Br J Cancer 82, 1393–1395 (2000). https://doi.org/10.1054/bjoc.1999.1124
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1124
Keywords
This article is cited by
-
The role of 18F-fluorodeoxyglucose positron emission tomography in gestational trophoblastic tumours: a pilot study
European Journal of Nuclear Medicine and Molecular Imaging (2006)
-
Low-risk persistent gestational trophoblastic disease treated with low-dose methotrexate: efficacy, acute and long-term effects
British Journal of Cancer (2003)